Overview LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes Status: Completed Trial end date: 2007-08-01 Target enrollment: Participant gender: Summary Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes Phase: Phase 3 Details Lead Sponsor: AstraZenecaTreatments: AtorvastatinAtorvastatin CalciumCalciumRosuvastatin Calcium